Salarius Pharmaceuticals (SLRX) Institutional Ownership $0.79 +0.00 (+0.09%) Closing price 05/21/2025 03:58 PM EasternExtended Trading$0.78 0.00 (-0.38%) As of 04:01 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Salarius Pharmaceuticals (NASDAQ:SLRX)CurrentInstitutional OwnershipPercentage11.88%Number ofInstitutional Buyers(last 12 months)0Number ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$145.78K Get SLRX Insider Trade Alerts Want to know when executives and insiders are buying or selling Salarius Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data SLRX Institutional Buying and Selling by Quarter Salarius Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2024 Armistice Capital LLC22,750$54K0.0%-72.9%3.811% 2/13/2024 Armistice Capital LLC88,000$57K0.0%-60.9%2.234% 11/15/2023 Armistice Capital LLC225,000$148K0.0%+105.2%5.711% 11/15/2021 HighTower Advisors LLC26,000$26K0.0%N/A0.058% 11/9/2021BlackRock Inc.116,309$119K0.0%-13.7%0.260% 8/25/2021 Marshall Wace LLP174,474$185K0.0%+29.6%0.390% 8/17/2021 X Square Capital LLC100,458$106K0.1%-39.4%0.224% 8/16/2021 Maven Securities LTD1,316,205$1.37M0.1%-31.7%2.939% 8/16/2021 State Street Corp142,552$151K0.0%N/A0.318% 8/16/2021 Sabby Management LLC249,033$264K0.0%-6.7%0.556% Get the Latest News and Ratings for SLRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Salarius Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 8/16/2021 Marshall Wace LLP174,474$185K0.0%+29.6%0.390% 8/13/2021 Northern Trust Corp65,022$69K0.0%+25.9%0.145% 8/13/2021 Geode Capital Management LLC277,035$293K0.0%+124.4%0.619% 8/13/2021 Vanguard Group Inc.1,544,724$1.64M0.0%+8.7%3.450% 8/12/2021 Dimensional Fund Advisors LP36,634$39K0.0%-40.8%0.082% 5/19/2021 Worth Venture Partners LLC424,800$629K0.3%+17.8%0.949% 5/18/2021 Millennium Management LLC28,675$42K0.0%+40.5%0.064% 5/18/2021 Silverarc Capital Management LLC1,992,181$2.95M1.6%N/A4.450% 5/14/2021 Dimensional Fund Advisors LP61,839$92K0.0%N/A0.138% 5/13/2021 Renaissance Technologies LLC237,601$352K0.0%N/A0.531% 5/13/2021 Kepos Capital LP548,054$811K0.1%+338.4%1.225% 5/13/2021 X Square Capital LLC165,708$245K0.1%+186.4%0.370% 5/12/2021 Northern Trust Corp51,648$76K0.0%+248.6%0.115% 5/12/2021 Geode Capital Management LLC123,461$182K0.0%+573.5%0.276% 5/12/2021Granite Point Capital Management L.P.1,563,561$2.31M0.1%N/A3.495% (Data available from 1/1/2016 forward) SLRX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of SLRX shares? During the previous two years, the following institutional investors and hedge funds held shares of Salarius Pharmaceuticals shares: Armistice Capital LLC ($54K).Learn more on SLRX's institutional investors. What percentage of Salarius Pharmaceuticals stock is owned by institutional investors? 11.88% of Salarius Pharmaceuticals stock is owned by institutional investors. Learn more on SLRX's institutional investor holdings. Which institutional investors have been buying Salarius Pharmaceuticals stock? The following institutional investors have purchased Salarius Pharmaceuticals stock in the last 24 months: Armistice Capital LLC ($115.36K). How much institutional buying is happening at Salarius Pharmaceuticals? Institutional investors have bought a total of 115,364 shares in the last 24 months. This purchase volume represents approximately $607.18K in transactions. Which Salarius Pharmaceuticals major shareholders have been selling company stock? The following institutional investors have sold Salarius Pharmaceuticals stock in the last 24 months: Armistice Capital LLC ($198.25K). How much institutional selling is happening at Salarius Pharmaceuticals? Institutional investors have sold a total of 198,250 shares in the last 24 months. This volume of shares sold represents approximately $858.18K in transactions. Related Companies INDP Institutional Ownership GNPX Institutional Ownership AIM Institutional Ownership BFRI Institutional Ownership ALBT Institutional Ownership SNGX Institutional Ownership LIPO Institutional Ownership NLSP Institutional Ownership MYNZ Institutional Ownership GTBP Institutional Ownership This page (NASDAQ:SLRX) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredThe DOJ Just Said Your Money Isn’t YoursWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredA new financial chapter Porter Stansberry says what happened last week could become the defining legacy of his financial publishing ca...Porter & Company | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s Bitcoin Reserve is No Accident…How everyday investors are building crypto wealth (step-by-step guide) Don't wait. The window for maximum g...Crypto 101 Media | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Salarius Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Salarius Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SLRX Stock Free SLRX Stock Alerts